These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36604245)

  • 1. High-dose Chemotherapy Impairs Cardiac Autonomic Control of Hospitalized Cancer Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation.
    de Almeida LB; Laterza MC; Rondon MUPB; Toschi-Dias E; de Matos LDNJ; Oliveira CC; Trevizan PF; Martinez DG
    Clin Lymphoma Myeloma Leuk; 2023 Mar; 23(3):e131-e138. PubMed ID: 36604245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart rate variability and heart rate turbulence in patients with hematologic malignancies subjected to high-dose chemotherapy in the course of hematopoietic stem cell transplantation.
    Poręba M; Poręba R; Gać P; Usnarska-Zubkiewicz L; Pilecki W; Piotrowicz E; Piotrowicz R; Rusiecki L; Kuliczkowski K; Mazur G; Sobieszczańska M
    Ann Noninvasive Electrocardiol; 2014 Mar; 19(2):157-65. PubMed ID: 24206437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial measurements of cardiac biomarkers in patients after allogeneic hematopoietic stem cell transplantation.
    Roziakova L; Bojtarova E; Mistrik M; Dubrava J; Gergel J; Lenkova N; Mladosievicova B
    J Exp Clin Cancer Res; 2012 Feb; 31(1):13. PubMed ID: 22321767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Complement Activating Collectins and Associated Serine Proteases in Patients With Hematological Malignancies, Receiving High-Dose Chemotherapy, and Autologous Hematopoietic Stem Cell Transplantations (Auto-HSCT).
    Świerzko AS; Michalski M; Sokołowska A; Nowicki M; Eppa Ł; Szala-Poździej A; Mitrus I; Szmigielska-Kapłon A; Sobczyk-Kruszelnicka M; Michalak K; Gołos A; Wierzbowska A; Giebel S; Jamroziak K; Kowalski ML; Brzezińska O; Thiel S; Jensenius JC; Kasperkiewicz K; Cedzyński M
    Front Immunol; 2018; 9():2153. PubMed ID: 30294330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative management after high-dose chemotherapy with autologous or allogeneic hematopoietic stem cell transplantation for pediatric solid tumors.
    Uehara S; Oue T; Nakahata K; Nara K; Ueno T; Owari M; Usui N; Miyamura T; Hashii Y
    Eur J Pediatr Surg; 2015 Feb; 25(1):118-22. PubMed ID: 25111275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Von Willebrand Factor and Platelet Levels before Conditioning Chemotherapy Indicate Bone Marrow Regeneration following Autologous Hematopoietic Stem Cell Transplantation.
    Radnay Z; Illés Á; Udvardy M; Prohászka Z; Sinkovits G; Csányi MC; Kellermayer M; Kiss A; Hársfalvi J
    Transplant Cell Ther; 2022 Dec; 28(12):830.e1-830.e7. PubMed ID: 36058547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
    Cavo M; Gay F; Beksac M; Pantani L; Petrucci MT; Dimopoulos MA; Dozza L; van der Holt B; Zweegman S; Oliva S; van der Velden VHJ; Zamagni E; Palumbo GA; Patriarca F; Montefusco V; Galli M; Maisnar V; Gamberi B; Hansson M; Belotti A; Pour L; Ypma P; Grasso M; Croockewit A; Ballanti S; Offidani M; Vincelli ID; Zambello R; Liberati AM; Andersen NF; Broijl A; Troia R; Pascarella A; Benevolo G; Levin MD; Bos G; Ludwig H; Aquino S; Morelli AM; Wu KL; Boersma R; Hajek R; Durian M; von dem Borne PA; Caravita di Toritto T; Zander T; Driessen C; Specchia G; Waage A; Gimsing P; Mellqvist UH; van Marwijk Kooy M; Minnema M; Mandigers C; Cafro AM; Palmas A; Carvalho S; Spencer A; Boccadoro M; Sonneveld P
    Lancet Haematol; 2020 Jun; 7(6):e456-e468. PubMed ID: 32359506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac toxicity of high-dose cyclophosphamide and melphalan in patients with multiple myeloma treated with tandem autologous hematopoietic stem cell transplantation.
    Zver S; Zadnik V; Černelč P; Koželj M
    Int J Hematol; 2008 Sep; 88(2):227-236. PubMed ID: 18548196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease and its management in children and adults undergoing hematopoietic stem cell transplantation.
    Rotz SJ; Ryan TD; Hayek SS
    J Thromb Thrombolysis; 2021 May; 51(4):854-869. PubMed ID: 33230704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exacerbated hemodynamic response during exercise in cancer patients prior to autologous hematopoietic stem cell transplantation.
    Dias ALM; Laterza MC; Mira PAC; Freitas IMG; Trevizan PF; Martinez DG; de Almeida LB
    Support Care Cancer; 2021 Jul; 29(7):3831-3838. PubMed ID: 33245409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echocardiographic evaluation of the early cardiotoxic effect of hematopoietic stem cell transplantation in patients with hematologic malignancies.
    Poręba M; Gać P; Usnarska-Zubkiewicz L; Pilecki W; Kuliczkowski K; Mazur G; Sobieszczańska M; Poręba R
    Leuk Lymphoma; 2016 Sep; 57(9):2119-25. PubMed ID: 26762118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of cardiac bio-markers in monitoring of cardiotoxicity after hematopoietic stem cell transplantation].
    Roziaková L; Mladosievičová B
    Vnitr Lek; 2013 Nov; 59(11):996-1002. PubMed ID: 24279444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical features of fatal cyclophosphamide-induced cardiotoxicity in a conditioning regimen for allogeneic hematopoietic stem cell transplantation (allo-HSCT).
    Ishida S; Doki N; Shingai N; Yoshioka K; Kakihana K; Sakamaki H; Ohashi K
    Ann Hematol; 2016 Jun; 95(7):1145-50. PubMed ID: 27079957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the impact of treatment with hematopoietic stem cells transplantation (HSCT) on biochemical markers of heart function and novel electrocardiographic markers of repolarization in patients with hematological malignancies.
    Poręba M; Gać P; Usnarska-Zubkiewicz L; Pilecki W; Kuliczkowski K; Mazur G; Gonerska M; Sobieszczańska M; Poręba R
    Med Oncol; 2018 Oct; 35(12):162. PubMed ID: 30382530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of cardiotoxicity during haemopoietic stem cell transplantation with plasma brain natriuretic peptide.
    Snowden JA; Hill GR; Hunt P; Carnoutsos S; Spearing RL; Espiner E; Hart DN
    Bone Marrow Transplant; 2000 Aug; 26(3):309-13. PubMed ID: 10967571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upfront autologous haematopoietic stem-cell transplantation versus carfilzomib-cyclophosphamide-dexamethasone consolidation with carfilzomib maintenance in patients with newly diagnosed multiple myeloma in England and Wales (CARDAMON): a randomised, phase 2, non-inferiority trial.
    Yong K; Wilson W; de Tute RM; Camilleri M; Ramasamy K; Streetly M; Sive J; Bygrave CA; Benjamin R; Chapman M; Chavda SJ; Phillips EH; Del Mar Cuadrado M; Pang G; Jenner R; Dadaga T; Kamora S; Cavenagh J; Clifton-Hadley L; Owen RG; Popat R
    Lancet Haematol; 2023 Feb; 10(2):e93-e106. PubMed ID: 36529145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous hematopoietic stem cell transplantation following high-dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomas.
    Peinemann F; Smith LA; Kromp M; Bartel C; Kröger N; Kulig M
    Cochrane Database Syst Rev; 2011 Feb; (2):CD008216. PubMed ID: 21328307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial Changes in Cardiac Strain and Contractility After Hematopoietic Stem Cell Transplantation in Patients with Hematologic Malignancies.
    Oka T; Tada Y; Oboshi M; Kamada R; Yasui T; Shioyama W; Nishikawa T; Hino A; Ishikawa J; Fujita M
    Int Heart J; 2021 May; 62(3):575-583. PubMed ID: 33994498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment for advanced testicular cancer with high-dose chemotherapy and autologous blood stem cell transplantation.
    Takahashi A; Miyao N; Masumori N; Takeda K; Shigyo M; Sasamura H; Sakamaki S; Niitsu Y; Tsukamoto T
    Int J Urol; 1998 Jan; 5(1):67-72; discussion 73. PubMed ID: 9535604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.